Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0B0SH
|
|||
Former ID |
DAP000868
|
|||
Drug Name |
Oxtriphylline
|
|||
Synonyms |
Choledyl; Cholegyl; Cholinophyllin; Cholinophylline; Filoral; Oxtrimethylline; Sabidal; Soliphylline; Teofilcolina; Teokolin; Theoxylline; Choline theophylline salt; Cholini theophyllinas; Colina teofillinato; Colina teofillinato [DCIT]; Oxtriphylline [USAN]; Oxtriphylline pediatric; Teofilinato de colina; Theophyllinate de choline; Theophylline cholinate; Theophylline salt of choline; Choledyl SA 400; Zy 15061; Choledyl (TN); Cholini theophyllinas [INN-Latin]; Teofilinato de colina [INN-Spanish]; Theophyllinate de choline[INN-French]; Choline salt with theophylline (1:1); Theophylline, compd. with choline; Choline, compd. with theophylline (1:1); Choline, hydroxide, compd. with theophylline (1:1); Ethanaminium, 2-hydroxy-N,N,N-trimethyl-, salt with 3,7-dihydro-1,3-dimethylpurine-2,6-dione; Ethanaminium, 2-hydroxy-N,N,N-trimethyl-, salt with 3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione; Ethanaminium, 2-hydroxy-N,N,N-trimethyl-, salt with 3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione (1:1); (2-Hydroxyethyl)trimethylammonium compound with theophylline; 1,3-dimethyl-7H-purine-2,6-dione; 1H-Purine-2,6-dione, 3,7-dihydro-1,3-dimethyl-, ion(1-), 2-hydroxy-N,N,N-trimethylethanaminium
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Cough [ICD-11: MD12; ICD-10: R05; ICD-9: 786.2] | Approved | [1] | |
Therapeutic Class |
Bronchodilator Agents
|
|||
Structure |
Download2D MOL
|
|||
Formula |
C12H21N5O3
|
|||
Canonical SMILES |
CN1C(=C2C(=NC=N2)N(C1=O)C)[O-].C[N+](C)(C)CCO
|
|||
InChI |
1S/C7H8N4O2.C5H14NO/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13;1-6(2,3)4-5-7/h3,12H,1-2H3;7H,4-5H2,1-3H3/q;+1/p-1
|
|||
InChIKey |
SOELXOBIIIBLRJ-UHFFFAOYSA-M
|
|||
CAS Number |
CAS 4499-40-5
|
|||
PubChem Compound ID | ||||
PubChem Substance ID | ||||
ADReCS Drug ID | BADD_D01642 | |||
SuperDrug ATC ID |
R03DA02
|
|||
SuperDrug CAS ID |
cas=004499405
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Phosphodiesterase 3 (PDE3) | Target Info | Modulator | [2] |
Phosphodiesterase 4 (PDE4) | Target Info | Modulator | [2] |
References | Top | |||
---|---|---|---|---|
REF 1 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 086742. | |||
REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.